Related Experiment Video
Updated: Jul 31, 2026

The Application Of Permanent Middle Cerebral Artery Ligation in the Mouse
Published on: July 25, 2011
Complement component C3 mediates inflammatory injury following focal cerebral ischemia
J Mocco1, William J Mack, Andrew F Ducruet
1Department of Neurosurgery, Columbia University, 710 W 168th St, New York, NY 10032, USA.
Abstract:
The complement cascade has been implicated in ischemia/reperfusion injury, and recent studies have shown that complement inhibition is a promising treatment option for acute stroke. The development of clinically useful therapies has been hindered, however, by insufficient understanding of which complement subcomponents contribute to post-ischemic injury. To address this issue, we subjected mice deficient in selected complement proteins (C1q, C3, C5) to transient focal cerebral ischemia. Of the strains investigated, only C3-/- mice were protected, as demonstrated by 34% reductions in both infarct volume (P<0.01) and neurological deficit score (P<0.05). C3-deficient mice also manifested decreased granulocyte infiltration (P<0.02) and reduced oxidative stress (P<0.05). Finally, administration of a C3a-receptor antagonist resulted in commensurate neurological improvement and stroke volume reduction (P<0.05). Together, these results establish C3 activation as the key constituent in complement-related inflammatory tissue injury following stroke and suggest a C3a anaphylatoxin-mediated mechanism.
Insights
Complement component 3 (C3) activation is critical for stroke-related inflammation and injury. Inhibiting C3 or its receptor reduces infarct volume and neurological deficits in stroke models.
Area of Science:
- Neuroscience
- Immunology
- Cardiovascular Research
Background:
- Complement cascade activation contributes to ischemia/reperfusion injury, particularly in acute stroke.
- Understanding specific complement subcomponents involved in post-ischemic injury is crucial for developing effective therapies.
Purpose of the Study:
- To investigate the role of complement proteins C1q, C3, and C5 in focal cerebral ischemia.
- To determine if C3 activation is a key mediator of stroke-related inflammatory injury.
Main Methods:
- Transient focal cerebral ischemia was induced in mice deficient in C1q, C3, or C5.
- Infarct volume, neurological deficit scores, granulocyte infiltration, and oxidative stress were assessed.
- The effect of a C3a-receptor antagonist was evaluated.
Main Results:
- Only C3-deficient mice showed significant protection, with 34% reductions in infarct volume and neurological deficits.
- C3 deficiency led to decreased granulocyte infiltration and reduced oxidative stress.
- C3a-receptor antagonist administration mirrored these protective effects.
Conclusions:
- Complement component 3 (C3) activation is the primary driver of complement-mediated inflammatory injury following stroke.
- Targeting C3 activation or its receptor offers a promising therapeutic strategy for acute stroke.
More Related Videos
Related Concept Videos
Acute Inflammation III: Local and Systemic Effects
Ischemic Stroke ll: Pathophysiology
Bacterial Meningitis II: Pathophysiology
Cerebral Edema ll: Pathophysiology
Cytotoxic Edema: Pathophysiology

